MedPath
HSA Product

Onzapin ODT Orodispersible Tablet 10 mg

Product approved by Health Sciences Authority (SG)

Basic Information

Onzapin ODT Orodispersible Tablet 10 mg

TABLET, ORALLY DISINTEGRATING

Regulatory Information

SIN13958P

May 5, 2011

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XN05AH03

Company Information

Actavis Ltd.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Active Ingredients

Olanzapine (form 1)

Strength: 10.0 mg

© Copyright 2025. All Rights Reserved by MedPath